Teva Launches Generic Version of Cialis in the U.S.
2018年9月28日 - 4:49AM
Dow Jones News
Teva Pharmaceutical Industries Ltd. (TEVA) on Thursday announced
the exclusive first-to-file launch of a generic version of Cialis
in the U.S.
Tadalafil tablets are a phosphodiesterase 5 inhibitor indicated
for the treatment of erectile dysfunction, the signs and symptoms
of benign prostatic hyperplasia, and both ED and the signs and
symptoms of BPH, the company said.
Eli Lilly and Company are the makers of Cialis.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 27, 2018 15:34 ET (19:34 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
過去 株価チャート
から 6 2024 まで 7 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
過去 株価チャート
から 7 2023 まで 7 2024
